Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)
|
December 1, 1987
Human T cells specifically activated against autologous malignant melanoma
C L Slingluff, T L Darrow, H F Seigler
Annals of Plastic Surgery
|
January 11, 1992
Recurrent malignant melanoma: the identification of prognostic factors to predict survival
D S Reintgen, C Cox, C L Slingluff, et al.
International Journal of Dermatology
|
February 13, 2001
Cancer of the male breast
J C English, C Middleton, J W Patterson, et al.
Cancer Research
|
February 1, 1990
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas
N J Crowley, C L Slingluff, T L Darrow, et al.
Annals of Surgery
|
August 1, 1988
Lethal "thin" malignant melanoma. Identifying patients at risk
C L Slingluff, R T Vollmer, D S Reintgen, et al.
Journal of Biological Response Modifiers
|
August 1, 1990
Implications of leukoregulin to autologous tumor-specific human T-cell populations
C L Slingluff, H F Seigler, T L Darrow, et al.
Cancer
|
October 11, 1992
The annual risk of melanoma progression. Implications for the concept of cure
C L Slingluff, R K Dodge, W E Stanley, et al.
Annals of Surgery
|
May 1, 1990
Malignant melanoma arising during pregnancy. A study of 100 patients
C L Slingluff, D S Reintgen, R T Vollmer, et al.
Journal of the National Cancer Institute
|
September 7, 1988
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases
C L Slingluff, T Darrow, C Vervaert, et al.
Annals of Surgery
|
February 1, 1994
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients
C L Slingluff, K R Stidham, W M Ricci, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Archives of Surgery (Chicago, Ill. : 1960)
|
December 1, 1987
Human T cells specifically activated against autologous malignant melanoma
C L Slingluff, T L Darrow, H F Seigler
Annals of Plastic Surgery
|
January 11, 1992
Recurrent malignant melanoma: the identification of prognostic factors to predict survival
D S Reintgen, C Cox, C L Slingluff, et al.
International Journal of Dermatology
|
February 13, 2001
Cancer of the male breast
J C English, C Middleton, J W Patterson, et al.
Cancer Research
|
February 1, 1990
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas
N J Crowley, C L Slingluff, T L Darrow, et al.
Annals of Surgery
|
August 1, 1988
Lethal "thin" malignant melanoma. Identifying patients at risk
C L Slingluff, R T Vollmer, D S Reintgen, et al.
Journal of Biological Response Modifiers
|
August 1, 1990
Implications of leukoregulin to autologous tumor-specific human T-cell populations
C L Slingluff, H F Seigler, T L Darrow, et al.
Cancer
|
October 11, 1992
The annual risk of melanoma progression. Implications for the concept of cure
C L Slingluff, R K Dodge, W E Stanley, et al.
Annals of Surgery
|
May 1, 1990
Malignant melanoma arising during pregnancy. A study of 100 patients
C L Slingluff, D S Reintgen, R T Vollmer, et al.
Journal of the National Cancer Institute
|
September 7, 1988
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases
C L Slingluff, T Darrow, C Vervaert, et al.
Annals of Surgery
|
February 1, 1994
Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients
C L Slingluff, K R Stidham, W M Ricci, et al.
Page
of 6